Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
fda
7
×
immunotherapy
7
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
bristol-myers squibb
cancer immunotherapy
glaxosmithkline
novartis
scott gottlieb
abbvie
acquisition
acute myeloid leukemia
aimmune therapeutics
akcea therapeutics
What
days
roundup
annual
bio
biotech
cancer
celgene
industry
time
abbvie’s
according
agency
ahead
aimmune
airport
akcea
allergy
apocalypse
approval
approved
arrival
ash
awarded
barcelona
beds
biofourmis
biopharma
bucks
car
cases
celebrate
centers
chance
cigarettes
clinical
colleagues
companies
conference
control
corner
Language
unset
Current search:
immunotherapy
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
